Literature DB >> 19741045

Thyroid hormone receptors regulate adipogenesis and carcinogenesis via crosstalk signaling with peroxisome proliferator-activated receptors.

Changxue Lu1, Sheue-Yann Cheng.   

Abstract

Peroxisome proliferator-activated receptors (PPARs) and thyroid hormone receptors (TRs) are members of the nuclear receptor superfamily. They are ligand-dependent transcription factors that interact with their cognate hormone response elements in the promoters to regulate respective target gene expression to modulate cellular functions. While the transcription activity of each is regulated by their respective ligands, recent studies indicate that via multiple mechanisms PPARs and TRs crosstalk to affect diverse biological functions. Here, we review recent advances in the understanding of the molecular mechanisms and biological impact of crosstalk between these two important nuclear receptors, focusing on their roles in adipogenesis and carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19741045      PMCID: PMC3464095          DOI: 10.1677/JME-09-0107

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  101 in total

1.  Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis.

Authors:  Joel J Bergh; Hung-Yun Lin; Lawrence Lansing; Seema N Mohamed; Faith B Davis; Shaker Mousa; Paul J Davis
Journal:  Endocrinology       Date:  2005-03-31       Impact factor: 4.736

Review 2.  Activation of mitogen-activated protein kinases by peroxisome proliferator-activated receptor ligands: an example of nongenomic signaling.

Authors:  Olivia S Gardner; Brian J Dewar; Lee M Graves
Journal:  Mol Pharmacol       Date:  2005-07-14       Impact factor: 4.436

3.  Follicular thyroid tumors with the PAX8-PPARgamma1 rearrangement display characteristic genetic alterations.

Authors:  Ludovic Lacroix; Vladimir Lazar; Stefan Michiels; Hugues Ripoche; Philippe Dessen; Monique Talbot; Bernard Caillou; Jean-Pierre Levillain; Martin Schlumberger; Jean-Michel Bidart
Journal:  Am J Pathol       Date:  2005-07       Impact factor: 4.307

4.  Delineation, functional validation, and bioinformatic evaluation of gene expression in thyroid follicular carcinomas with the PAX8-PPARG translocation.

Authors:  Thomas J Giordano; Amy Y M Au; Rork Kuick; Dafydd G Thomas; Daniel R Rhodes; Kenneth G Wilhelm; Michelle Vinco; David E Misek; Donita Sanders; Zhaowen Zhu; Raffaele Ciampi; Samir Hanash; Arul Chinnaiyan; Roderick J Clifton-Bligh; Bruce G Robinson; Yuri E Nikiforov; Ronald J Koenig
Journal:  Clin Cancer Res       Date:  2006-04-01       Impact factor: 12.531

5.  Expression profiling reveals a distinct transcription signature in follicular thyroid carcinomas with a PAX8-PPAR(gamma) fusion oncogene.

Authors:  Weng-Onn Lui; Theodoros Foukakis; Johan Lidén; Srinivasan R Thoppe; Trisha Dwight; Anders Höög; Jan Zedenius; Göran Wallin; Mark Reimers; Catharina Larsson
Journal:  Oncogene       Date:  2005-02-17       Impact factor: 9.867

6.  Recombinant human PPAR-beta/delta ligand-binding domain is locked in an activated conformation by endogenous fatty acids.

Authors:  Stewart A Fyffe; Magnus S Alphey; Lori Buetow; Terry K Smith; Michael A J Ferguson; Morten D Sørensen; Fredrik Björkling; William N Hunter
Journal:  J Mol Biol       Date:  2006-01-04       Impact factor: 5.469

7.  Thyroid hormone receptor beta mutants: Dominant negative regulators of peroxisome proliferator-activated receptor gamma action.

Authors:  Osamu Araki; Hao Ying; Fumihiko Furuya; Xuguang Zhu; Sheue-Yann Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-31       Impact factor: 11.205

8.  PPARgamma insufficiency promotes follicular thyroid carcinogenesis via activation of the nuclear factor-kappaB signaling pathway.

Authors:  Y Kato; H Ying; L Zhao; F Furuya; O Araki; M C Willingham; S-Y Cheng
Journal:  Oncogene       Date:  2006-05-04       Impact factor: 9.867

9.  Thyroid hormone receptor beta1 in normal colon and colorectal cancer-association with differentiation, polypoid growth type and K-ras mutations.

Authors:  Tuomo T Hörkkö; Karoliina Tuppurainen; Susannah M George; Petra Jernvall; Tuomo J Karttunen; Markus J Mäkinen
Journal:  Int J Cancer       Date:  2006-04-01       Impact factor: 7.396

Review 10.  PPAR delta: a dagger in the heart of the metabolic syndrome.

Authors:  Grant D Barish; Vihang A Narkar; Ronald M Evans
Journal:  J Clin Invest       Date:  2006-03       Impact factor: 14.808

View more
  25 in total

1.  Thyroid receptor antagonism as a contributory mechanism for adipogenesis induced by environmental mixtures in 3T3-L1 cells.

Authors:  Christopher D Kassotis; Erin M Kollitz; Kate Hoffman; Julie Ann Sosa; Heather M Stapleton
Journal:  Sci Total Environ       Date:  2019-02-18       Impact factor: 7.963

2.  Chemical Mixtures Isolated from House Dust Disrupt Thyroid Receptor β Signaling.

Authors:  Erin M Kollitz; Christopher D Kassotis; Kate Hoffman; P Lee Ferguson; Julie Ann Sosa; Heather M Stapleton
Journal:  Environ Sci Technol       Date:  2018-09-25       Impact factor: 9.028

3.  Thyroid Receptor Antagonism of Chemicals Extracted from Personal Silicone Wristbands within a Papillary Thyroid Cancer Pilot Study.

Authors:  Christopher D Kassotis; Nicholas J Herkert; Stephanie C Hammel; Kate Hoffman; Qianyi Xia; Seth W Kullman; Julie Ann Sosa; Heather M Stapleton
Journal:  Environ Sci Technol       Date:  2020-11-13       Impact factor: 9.028

Review 4.  Endocrine disrupting chemicals and the developmental programming of adipogenesis and obesity.

Authors:  Amanda Janesick; Bruce Blumberg
Journal:  Birth Defects Res C Embryo Today       Date:  2011-03

Review 5.  A review of species differences in the control of, and response to, chemical-induced thyroid hormone perturbations leading to thyroid cancer.

Authors:  John R Foster; Helen Tinwell; Stephanie Melching-Kollmuss
Journal:  Arch Toxicol       Date:  2021-01-05       Impact factor: 5.153

6.  Thyroid hormone receptor sumoylation is required for preadipocyte differentiation and proliferation.

Authors:  Yan-Yun Liu; Stephen Ayers; Anna Milanesi; Xiaochun Teng; Sina Rabi; Ysutada Akiba; Gregory A Brent
Journal:  J Biol Chem       Date:  2015-01-08       Impact factor: 5.157

7.  PPARs: Nuclear Receptors Controlled by, and Controlling, Nutrient Handling through Nuclear and Cytosolic Signaling.

Authors:  Maria Moreno; Assunta Lombardi; Elena Silvestri; Rosalba Senese; Federica Cioffi; Fernando Goglia; Antonia Lanni; Pieter de Lange
Journal:  PPAR Res       Date:  2010-08-01       Impact factor: 4.964

Review 8.  Thyroid hormone actions in liver cancer.

Authors:  Sheng-Ming Wu; Wan-Li Cheng; Crystal D Lin; Kwang-Huei Lin
Journal:  Cell Mol Life Sci       Date:  2012-09-06       Impact factor: 9.261

9.  Extrinsic and intrinsic regulation of DOR/TP53INP2 expression in mice: effects of dietary fat content, tissue type and sex in adipose and muscle tissues.

Authors:  Carolin Fromm-Dornieden; Oleksandr Lytovchenko; Silvia von der Heyde; Nina Behnke; Sebastian Hogl; Janina Berghoff; Frederik Köpper; Lennart Opitz; Ulla Renne; Andreas Hoeflich; Tim Beissbarth; Bertram Brenig; Bernhard G Baumgartner
Journal:  Nutr Metab (Lond)       Date:  2012-09-21       Impact factor: 4.169

10.  Characterization of adipogenic, PPARγ, and TRβ activities in house dust extracts and their associations with organic contaminants.

Authors:  Christopher D Kassotis; Kate Hoffman; Allison L Phillips; Sharon Zhang; Ellen M Cooper; Thomas F Webster; Heather M Stapleton
Journal:  Sci Total Environ       Date:  2020-11-14       Impact factor: 7.963

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.